Funded Tech Companies
SpecificiT
Wondering who provided funding to SpecificiT? AmorChem, Sanderling Ventures and Accel-Rx Health Sciences Accelerator put venture money into this biopharmaceutical company.
Company Overview
Company Name
SpecificiT
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
1010 Sherbrooke St. West 408
Montreal QC, H3A 2R7
Canada
Montreal QC, H3A 2R7
Canada
Phone
Website
Email Address
Company Background Information
Overview
SpecificiT Pharma Inc., a privately held biopharmaceutical company focused on developing innovative personalized cancer immunotherapies. SpecificiT is developing cellular therapies for hematological cancers which to date, cannot be treated with chimeric antigen receptor modified T cells (CAR-T) therapies.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/12/2017
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Pierre Beauparlant
Chief Financial Officer
Michael Dixon
Chief Operating Officer
Marc Lussier
VP - Manufacturing
Frederick Miesowicz
Company Investors
- AmorChem (Inès Holzbaur)
- Sanderling Ventures (Pierre Beauparlant)
- Accel-Rx Health Sciences Accelerator (Natalie Dakers)
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs